← All organizations
Highest phase reached
Phase 4
First clinical trial
Jul 1, 2006Last known activity
Oct 22, 2024
Timeline
1840s
- Jun 1, 1845
Kantonsspital Graubünden— Founded
Drugs by trial phase (28 distinct, 21 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (17 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Other trials (4 own, 0 via acquisition)
Indications
Studied for
- Carcinoma, Non-Small-Cell Lung
- Colorectal Neoplasms
- Joint Diseases
- Leukemia
- Lymphoma
- Lymphoma, B-Cell
- Melanoma
- Mesothelioma
- Multiple Myeloma
- Neoplasm Metastasis
- Neoplasms
- Neoplasms, Plasma Cell
- Obstetric Labor, Premature
- Perinatal Death
- Plasmacytoma
- Premature Birth
- Prostatic Neoplasms
- Rectal Neoplasms
- Urinary Retention
Recent trials (31)
- NCT06401980OfficialPhase 2Oct 22, 2024
- NCT06435858OfficialPhase 4Sep 1, 2024
- NCT06435858Lead sponsorPhase 4Sep 1, 2024
- NCT06435858Sponsor investigatorPhase 4Sep 1, 2024
- NCT04630730Study chairPhase 2Dec 31, 2021
- NCT03808155Reponsible party - principal investigatorPhase 4Mar 31, 2019
- NCT03808155Lead sponsorPhase 4Mar 31, 2019
- NCT03808155Overall official - principal investigatorPhase 4Mar 31, 2019
- NCT03620669Study chairPhase 2Oct 1, 2018
- NCT03406650Study directorPhase 2May 15, 2018
- NCT03213301Study directorPhase 2Sep 28, 2017
- NCT03213301Study chairPhase 2Sep 28, 2017
- NCT02051218Study chairPhase 3Jul 1, 2014
- NCT02053311Study chairPhase 3Jun 1, 2014
- NCT01677897Reponsible party - principal investigatorPhase 2Aug 1, 2013
Details
- Founded
- Chur, CH Jun 1, 1845
- Last known activity
- Oct 22, 2024